JLens 500 Jewish Advocacy U.S. ETF (NYSEARCA:TOV – Get Free Report) saw a significant decline in short interest in the month of May. As of May 15th, there was short interest totaling 6,070 shares, a decline of 95.5% from the April 30th total of 136,361 shares. Based on an average trading volume of 60,531 shares, the short-interest ratio is presently 0.1 days. Approximately 0.1% of the shares of the company are sold short.
Institutional Investors Weigh In On JLens 500 Jewish Advocacy U.S. ETF
A number of hedge funds have recently made changes to their positions in TOV. Captrust Financial Advisors purchased a new stake in shares of JLens 500 Jewish Advocacy U.S. ETF in the second quarter worth about $6,038,000. Bank of New York Mellon Corp lifted its position in shares of JLens 500 Jewish Advocacy U.S. ETF by 66.7% during the first quarter. Bank of New York Mellon Corp now owns 71,189 shares of the company’s stock worth $1,946,000 after purchasing an additional 28,496 shares during the last quarter. Finally, JPMorgan Chase & Co. bought a new stake in shares of JLens 500 Jewish Advocacy U.S. ETF during the third quarter worth $25,000.
JLens 500 Jewish Advocacy U.S. ETF Stock Up 0.5%
NYSEARCA:TOV traded up $0.17 during mid-day trading on Thursday, hitting $31.78. 11,914 shares of the company traded hands, compared to its average volume of 14,982. The stock’s fifty day moving average price is $29.45 and its 200-day moving average price is $28.99. JLens 500 Jewish Advocacy U.S. ETF has a one year low of $24.55 and a one year high of $31.79. The firm has a market cap of $239.30 million, a price-to-earnings ratio of 25.69 and a beta of 1.04.
JLens 500 Jewish Advocacy U.S. ETF Company Profile
The JLens 500 Jewish Advocacy U.S. ETF (TOV) is an exchange-traded fund that is based on the JLens 500 Jewish Advocacy U.S. index. The fund tracks an index of large-cap US stocks while employing a methodology that seeks to align stock selection and weighting with Jewish value pillars. TOV was launched on Feb 26, 2025 and is issued by JLens.
Read More
- Five stocks we like better than JLens 500 Jewish Advocacy U.S. ETF
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for JLens 500 Jewish Advocacy U.S. ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JLens 500 Jewish Advocacy U.S. ETF and related companies with MarketBeat.com's FREE daily email newsletter.
